Literature DB >> 18574224

Dysmenorrhea in adolescents.

Zeev Harel1.   

Abstract

Dysmenorrhea is the most common gynecologic complaint among adolescent females. Dysmenorrhea in adolescents is usually primary, and is associated with normal ovulatory cycles and with no pelvic pathology. In approximately 10% of adolescents with severe dysmenorrheic symptoms, pelvic abnormalities such as endometriosis or uterine anomalies may be found. Potent prostaglandins and leukotrienes play an important role in generating the symptoms of dysmenorrhea. Nonsteroidal anti-inflammatory drugs (NSAIDs) are the most common pharmacologic treatment for dysmenorrhea. A loading dose of NSAIDs (typically twice the regular dose) should be used as initial treatment for dysmenorrhea in adolescents, followed by a regular dose until symptoms abate. Adolescents with symptoms that do not respond to treatment with NSAIDs for three menstrual periods should be offered hormonal treatment such as combined estrogen/progestin oral contraceptive pills for three menstrual cycles. Adolescents with dysmenorrhea who do not respond to this treatment should be evaluated for secondary causes of dysmenorrhea. The adolescent care provider's role is to explain the pathophysiology of dysmenorrhea to every adolescent female, address any concern that the patient has about her menstrual period, and review effective treatment options for dysmenorrhea with the patient.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18574224     DOI: 10.1196/annals.1429.007

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  15 in total

1.  Post-resection outcomes for pediatric ovarian neoplasm: is ovarian-preserving surgery a good option?

Authors:  Nima Azarakhsh; Sandra Grimes; Pranit N Chotai; Claudette Shephard; Eunice Y Huang
Journal:  Pediatr Surg Int       Date:  2016-10-13       Impact factor: 1.827

2.  Incidences of menstrual cycle abnormalities in adolescence, and matches between the age at menarche and the development of menstrual cycle abnormalities.

Authors:  Mercedes Juliana Art; Daniela Doerfler
Journal:  Wien Med Wochenschr       Date:  2010-08

3.  Rates of Anovulation in Adolescents and Young Adults with Moderate to Severe Primary Dysmenorrhea and Those without Primary Dysmenorrhea.

Authors:  Laura C Seidman; Kathleen M Brennan; Andrea J Rapkin; Laura A Payne
Journal:  J Pediatr Adolesc Gynecol       Date:  2017-10-07       Impact factor: 1.814

4.  The Relationship Between Androgens and Days per Month of Period Pain, Pelvic Pain, Headache, and TLR4 Responsiveness of Peripheral Blood Mononuclear Cells in Young Women with Dysmenorrhoea.

Authors:  Susan F Evans; Yuen Kwok; Ann Solterbeck; Carmen Pyragius; Mary Louise Hull; Mark R Hutchinson; Paul Rolan
Journal:  J Pain Res       Date:  2021-03-03       Impact factor: 3.133

5.  Auricular acupressure combined with an internet-based intervention or alone for primary dysmenorrhea: a control study.

Authors:  Mei-Ling Yeh; Yu-Ling Hung; Hsing-Hsia Chen; Jaung-Geng Lin; Yu-Jen Wang
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-03       Impact factor: 2.629

6.  Auricular acupressure to improve menstrual pain and menstrual distress and heart rate variability for primary dysmenorrhea in youth with stress.

Authors:  Yu-Jen Wang; Chin-Che Hsu; Mei-Ling Yeh; Jaung-Geng Lin
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-12       Impact factor: 2.629

7.  Effects of wheat germ extract on the severity and systemic symptoms of primary dysmenorrhea: a randomized controlled clinical trial.

Authors:  Maryam Atallahi; Sedigheh Amir Ali Akbari; Faraz Mojab; Hamid Alavi Majd
Journal:  Iran Red Crescent Med J       Date:  2014-08-05       Impact factor: 0.611

8.  Toll-Like Receptor Responsiveness of Peripheral Blood Mononuclear Cells in Young Women with Dysmenorrhea.

Authors:  Susan F Evans; Yuen H Kwok; Ann Solterbeck; Jiajun Liu; Mark R Hutchinson; M Louise Hull; Paul E Rolan
Journal:  J Pain Res       Date:  2020-03-09       Impact factor: 3.133

Review 9.  Piroxicam-β-cyclodextrin: a GI safer piroxicam.

Authors:  C Scarpignato
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

10.  Altered cytokine gene expression in peripheral blood monocytes across the menstrual cycle in primary dysmenorrhea: a case-control study.

Authors:  Hongyue Ma; Min Hong; Jinao Duan; Pei Liu; Xinsheng Fan; Erxin Shang; Shulan Su; Jianming Guo; Dawei Qian; Yuping Tang
Journal:  PLoS One       Date:  2013-02-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.